![]() |
市場調查報告書
商品編碼
1746730
2025-2033年日本行動醫療市場報告(按組件、服務、參與者和地區分類)Japan mHealth Market Report by Component, Service, Participant, and Region 2025-2033 |
2024年,日本行動醫療市場規模達72億美元。展望未來, IMARC Group預計到2033年,市場規模將達到514億美元,2025-2033年期間的複合年成長率(CAGR)為22.7%。領先企業廣泛採用創新技術來支持醫療保健產業,是推動市場成長的主要動力。
行動醫療 (mHealth) 是電子醫療領域的一個多元化分支,利用行動裝置和無線基礎設施收集病患資料。收集的資料旨在實現精準診斷,從而輔助診斷和治療各種疾病。 mHealth 在增強患者依從性和溝通能力、實現遠距患者監護以及幫助患者安全地與醫療服務提供者溝通和安排預約方面發揮著重要作用。因此,它在醫療供應鏈管理、診斷和治療流程支援、慢性病監護和管理以及提升個人健康意識等方面有著廣泛的應用。目前,mHealth 技術因其提供居家患者監護服務而獲得廣泛認可,尤其是在老年人群體中。
日本的行動醫療市場正經歷顯著成長,這主要得益於幾個關鍵因素。其中一個突出的促進因素是日本人口的快速老化,這導致對可透過行動裝置便捷存取的遠距病患監護和醫療保健服務的需求不斷成長。這種人口結構的變化使得人們更加重視居家照護和預防性保健措施,這使得行動醫療技術變得至關重要。此外,日本強大的技術基礎設施和智慧型手機的廣泛普及為行動醫療解決方案的蓬勃發展提供了有利環境。行動醫療應用程式和服務的便利性和可近性得到了患者和醫療服務提供者的一致好評。患者可以使用行動裝置追蹤自身健康狀況、獲取醫療資訊並與醫療專業人員溝通,而醫療服務提供者則可以從更高的患者參與度和即時資料監測中受益。此外,持續的新冠疫情加速了日本遠距醫療和行動醫療解決方案的普及。遠距會診和監護的需求凸顯了行動醫療技術在確保護理連續性的同時最大程度降低病毒傳播風險的重要性。此外,支持將行動醫療融入醫療保健生態系統的政府措施和法規預計將在未來幾年推動市場成長。
市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外,報告還提供了所有主要公司的詳細資料。
Japan mHealth market size reached USD 7.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 51.4 Billion by 2033, exhibiting a growth rate (CAGR) of 22.7% during 2025-2033. The widespread adoption of innovative technologies by leading players to support the healthcare industry is primarily driving the market growth.
Mobile health (mHealth) represents a diverse sector within electronic health, involving the utilization of mobile devices and wireless infrastructure to gather patient data. The data collected serves the purpose of achieving precise outcomes that aid in the diagnosis and treatment of various medical conditions. mHealth plays a role in enhancing medication adherence and communication, enabling remote patient monitoring, and empowering patients to securely communicate with healthcare service providers and arrange appointments. Consequently, it finds broad applications in healthcare supply chain management, providing support for diagnostic and treatment procedures, monitoring and managing chronic illnesses, and fostering increased health awareness among individuals. Presently, mHealth technology is gaining widespread recognition for delivering home-based patient monitoring services, particularly among the elderly population.
The mHealth market in Japan is experiencing notable growth driven by several key factors. One prominent driver is the country's rapidly aging population, which has resulted in an increased demand for remote patient monitoring and healthcare services that can be conveniently accessed through mobile devices. This demographic shift has led to a greater emphasis on home-based care and preventive health measures, making mHealth technologies highly relevant. Moreover, Japan's robust technological infrastructure and widespread smartphone adoption provide a favorable environment for mHealth solutions to flourish. The convenience and accessibility offered by mobile health applications and services have resonated well with both patients and healthcare providers. Patients can use mobile devices to track their health, access medical information, and communicate with healthcare professionals, while healthcare providers benefit from improved patient engagement and real-time data monitoring. Additionally, the ongoing COVID-19 pandemic has accelerated the adoption of telehealth and mHealth solutions in Japan. The need for remote consultations and monitoring has underscored the importance of mHealth technologies in ensuring continuity of care while minimizing the risk of virus transmission. Furthermore, government initiatives and regulations that support the integration of mHealth into the healthcare ecosystem are expected to fuel the market growth in the coming years.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.